Image source: Getty Images.
Drug giant Pfizer (NYSE: PFE) is back full circle. After years of Wall Street speculation about whether the company would split into stand-alone parts, CEO Ian Read recently announced management’s decision: no split.
Image source: Getty Images.
Drug giant Pfizer (NYSE: PFE) is back full circle. After years of Wall Street speculation about whether the company would split into stand-alone parts, CEO Ian Read recently announced management’s decision: no split.